These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11428531)
1. Lacrimal gland inflammation as the presenting sign of Crohn's disease. Hwang IP; Jordan DR; Acharya V Can J Ophthalmol; 2001 Jun; 36(4):212-3. PubMed ID: 11428531 [No Abstract] [Full Text] [Related]
2. Acute dacryoadenitis and Crohn's disease: findings and management. Dutt S; Cartwright MJ; Nelson CC Ophthalmic Plast Reconstr Surg; 1992; 8(4):295-9. PubMed ID: 1476981 [TBL] [Abstract][Full Text] [Related]
3. Dacryoadenitis and orbital myositis associated with lyme disease. Nieto JC; Kim N; Lucarelli MJ Arch Ophthalmol; 2008 Aug; 126(8):1165-6. PubMed ID: 18695120 [No Abstract] [Full Text] [Related]
4. Orbital inflammation and lyme disease. Pratt JW; Meyer DR; Wroblewski D; Carlson JA Ophthalmology; 2011 Sep; 118(9):1892.e1-2. PubMed ID: 21889662 [No Abstract] [Full Text] [Related]
5. Successful treatment of idiopathic orbital inflammation with infliximab: an alternative to conventional steroid-sparing agents. Miquel T; Abad S; Badelon I; Vignal C; Warzocha U; Larroche C; Morax S; Dhote R Ophthalmic Plast Reconstr Surg; 2008; 24(5):415-7. PubMed ID: 18806671 [TBL] [Abstract][Full Text] [Related]
6. Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer. Seth A; Anderson DP; Albiani DA; Barton JJ Can J Ophthalmol; 2009 Aug; 44(4):467-8. PubMed ID: 19606178 [No Abstract] [Full Text] [Related]
7. Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease. Amankonah TD; Strom CB; Vierling JM; Petrovic LM Am J Gastroenterol; 2001 Aug; 96(8):2520-2. PubMed ID: 11513216 [No Abstract] [Full Text] [Related]
9. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease. González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627 [No Abstract] [Full Text] [Related]
10. Are systemic corticosteroids useful in the management of orbital pseudotumors? Mombaerts I; Schlingemann RO; Goldschmeding R; Koornneef L Ophthalmology; 1996 Mar; 103(3):521-8. PubMed ID: 8600431 [TBL] [Abstract][Full Text] [Related]
11. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease. Feagan BG Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385 [No Abstract] [Full Text] [Related]
12. Interstitial nephritis in children with Crohn's disease. Benador N; Grimm P; Lemire J; Griswold W; Billman G; Reznik V Clin Pediatr (Phila); 2000 Apr; 39(4):253-4. PubMed ID: 10791141 [No Abstract] [Full Text] [Related]
13. Mesalamine and relapse prevention in Crohn's disease. Cottone M; Cammà C Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274 [No Abstract] [Full Text] [Related]
14. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence. Bauer WM; Brzezinski A; Lashner BA Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975 [TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease. Bosch X Gastroenterology; 1998 May; 114(5):1061-5. PubMed ID: 9558297 [TBL] [Abstract][Full Text] [Related]
18. Mesalamine in the treatment of active Crohn's disease. Dignass A; Marteau P Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152 [No Abstract] [Full Text] [Related]
19. Biopsy-proven recurrence of unilateral IgG4-related orbital inflammation after 20 years. Heidari P; Verdijk RM; van den Bosch WA; Paridaens D Orbit; 2014 Oct; 33(5):388-91. PubMed ID: 24911364 [TBL] [Abstract][Full Text] [Related]
20. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?]. Bischoff A MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159 [No Abstract] [Full Text] [Related] [Next] [New Search]